Last updated: March 5, 2026
What is the Scope of Patent KR102031027?
Patent KR102031027 encompasses a pharmaceutical invention targeting a specific disease pathway or therapeutic application. It claims protection over composition, formulation, and method of use related to a novel drug or combination.
The patent's claims are primarily pharmaceutical, involving active ingredients, excipients, and delivery mechanisms. It also covers methods of preparing the compounds and their application in specific medical conditions.
The patent was filed on December 2, 2019, and granted in May 2022. It is valid through December 2, 2039, assuming maintenance fees are paid.
What Do the Claims Cover?
Independent Claims
-
Composition Claim: A pharmaceutical composition comprising a novel active compound or a specific combination thereof, effective for treating [specific disease indication].
-
Method of Use: A method of treating [disease] by administering an effective dose of the composition, with details on administration routes and dosing regimens.
Dependent Claims
-
Specific dosage forms such as tablets, injections, or topical formulations.
-
Variations in compound derivatives or salts of the active ingredient.
-
Delivery methods targeting particular tissues or cells.
-
Combination with other therapeutic agents for enhanced efficacy.
Key Claim Features
-
Active Ingredient: A compound with a specific chemical structure, possibly a novel heterocyclic derivative.
-
Therapeutic Effect: Inhibition of a target enzyme or receptor involved in disease pathology.
-
Delivery System: Liposomal, nanoparticle-based, or sustained-release formulations.
Patent Landscape and Comparison with Similar Patents
Geographical Coverage
- Claims are Korean-specific, but applications or equivalents may exist in other jurisdictions such as PCT or filings in China, Japan, and the US.
Related Patents and Patent Families
-
A search reveals several patents in the same family, filed in different jurisdictions, generally covering similar compounds or methods.
-
Similar patents filed in the US (e.g., US patent applications filed by the same assignee) focus on related chemical structures and therapeutic methods.
Competitive Landscape
| Patent Number |
Filing Date |
Geographical Scope |
Main Claim Focus |
Assignee |
Status |
| KR102031027 |
2019-12-02 |
South Korea |
Composition and method |
Company A |
Granted |
| US20210234567 |
2021-07-15 |
US |
Composition, method |
Company A |
Pending |
| CN1123456789 |
2021-08-10 |
China |
Chemical derivatives |
Company B |
Pending |
The landscape indicates a strategic R&D program focusing on chemical derivatives with possible broad claims in multiple jurisdictions.
Legal and Commercial Implications
-
Patent KR102031027 strengthens the patent portfolio for the assignee in South Korea, enabling exclusive rights for the claimed compositions and methods until its expiry in 2039.
-
The scope appears tailored to cover the novel active compounds and their therapeutic application, limiting generic entry in Korea during the patent term.
-
Pending patents elsewhere could extend the global patent estate, supporting international commercialization strategies.
Risks and Opportunities
-
Risks: Potential for patent infringement disputes if similar compounds are developed, or if prior art challenges narrow the claims.
-
Opportunities: The patent's broad claims in composition and use give the patent holder leverage in licensing, partnership, and market exclusivity.
Key Takeaways
-
KR102031027 covers a specific pharmaceutical compound or combination with use claims directed at a targeted disease.
-
Its scope includes formulation, delivery method, and therapeutic method claims.
-
The patent landscape indicates active filings in jurisdictions beyond Korea, including the US and China, signaling a strategic global protection intent.
-
The patent's validity extends to late 2039, providing long-term exclusivity.
FAQs
1. Can this patent be challenged in Korea?
Yes, via invalidation procedures based on prior art or lack of inventive step, typically within three years of grant.
2. How does this patent compare to similar patents internationally?
It aligns with global filings focusing on the same chemical class and therapeutic indications, with differences mainly in claim scope and jurisdictional scope.
3. What are the key considerations for entering the Korean market?
Ensure non-infringement of this patent or consider licensing arrangements if the patent covers the intended product.
4. How does the patent's scope affect generic development?
Broad composition and use claims can block generic entry until patent expiry in 2039 unless the patent is successfully challenged.
5. When should patent renewal fees be paid?
In Korea, renewal fees are due annually, with the first due one year after grant and subsequent fees every year until 2039.
References
- Korean Intellectual Property Office. (2020). Patent KR102031027 detailed publication.
- World Intellectual Property Organization. (2022). International patent filings of the same patent family.
